Will Context Therapeutics Inc (CNTX) meet earnings estimates this quarter?

Patricia Turner

Currently, Context Therapeutics Inc’s (CNTX) stock is trading at $1.56, marking a gain of 1.30% from last night’s close. At this price, the stock is -22.00% below its 52-week high of $2.00 and 218.37% above its 52-week low of $0.49.

CNTX’s price to book ratio for the most recent quarter was 1.96, resulting in an 1.86 price to cash per share for the period.

How does Context Therapeutics Inc (CNTX) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.

Context Therapeutics Inc (CNTX): Earnings History

If we examine Context Therapeutics Inc’s recent earnings history, in the last quarter ended on 9/30/2025, it posted adjusted earnings per share of -$0.1, beating the consensus of -$0.09. In other words, it beat the consensus by -$0.01, resulting in a -14.29% surprise. In the 3 months period before the previous quarter which was closed on 9/30/2025, the stock recorded adjusted earnings per share of -$0.1 in contrast with the Outlook of -$0.09. That was a difference of -$0.01 and a surprise of -14.29%.

Context Therapeutics Inc (NASDAQ: CNTX) Ownership Details

I will give a breakdown of the key shareholders in Context Therapeutics Inc (CNTX). Recent figures show that the company’s insiders hold 1.18% of shares. A total of 39 institutional investors hold shares in the company, making 75.36% of its stock and 76.26% of its float.

Sep 30, 2025, it was reported that the Company’s largest institutional holder is MPM BIOIMPACT LLC holding total of 14.71 shares that make 16.01% of the company’s total number of shares and are currently priced at 22.65 million.

The securities firm Avidity Partners Management, LP holds 8.98 shares of CNTX, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 9.78%, and the holding percentage of shares is valued at 13.83 million.

US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.